When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Pharmaceutical marketing - Wikipedia

    en.wikipedia.org/wiki/Pharmaceutical_marketing

    Pharmaceutical companies are exploring online marketing as an alternative way to reach physicians. Emerging e-promotional activities include live video detailing, online events, electronic sampling, and physician customer service portals such as PV Updates, MDLinx, Aptus Health (former Physicians Interactive), and Epocrates .

  3. Direct-to-consumer advertising - Wikipedia

    en.wikipedia.org/wiki/Direct-to-consumer_advertising

    Pharmaceutical companies shifted the focus of their marketing efforts to licensed medical doctors in the 1970s, as the FDA mandated that only doctors could prescribe medicine. [8] However, a larger movement towards autonomy in health care decisions prompted the first prominent examples of direct-to-consumer advertising.

  4. Pharmaceutical Advertising Advisory Board - Wikipedia

    en.wikipedia.org/wiki/Pharmaceutical_Advertising...

    The Pharmaceutical Advertising Advisory Board (PAAB) is a Canadian not-for-profit organization based in Pickering, Ontario.Acting as a pseudo-regulatory body, PAAB offers review and pre-clearance services recognized by Health Canada to pharmaceutical companies and marketing agencies who wish to advertise directly to consumers and/or healthcare professionals.

  5. List of off-label promotion pharmaceutical settlements

    en.wikipedia.org/wiki/List_of_off-label...

    The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...

  6. Marketing of off-label use - Wikipedia

    en.wikipedia.org/wiki/Marketing_of_off-label_use

    The United States federal government is aggressively pursuing criminal and civil cases against pharmaceutical companies and their employees for promoting off-label uses of prescription drugs. [4] Between 2003 and 2008, U.S. federal prosecutors and state attorneys general brought more than a dozen cases against drug manufacturers for off-label ...

  7. Update on Regulatory Review of Lecanemab for Early Alzheimer ...

    lite.aol.com/tech/story/0022/20250131/9350947.htm

    TOKYO and CAMBRIDGE, Mass., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as treatment for early ...

  8. Co-promotion - Wikipedia

    en.wikipedia.org/wiki/Co-promotion

    Co-promotion is a marketing practice that allows two or more companies to combine their sales force in order to promote a product under the same brand name and price with a single marketing strategy. [1] It is considered as one of the two major forms of joint marketing (Kalb 1988). Co-marketing is the other form and these terms are often ...

  9. European Pharmaceutical Market Research Association

    en.wikipedia.org/wiki/European_Pharmaceutical...

    Due to the need for comparable and reliable information related to pharmaceutical product research and marketing in the 1960s, [6] various European companies sent their representatives to meet in Geneva on 5 May 1961. This meeting cause the foundation of the European Pharmaceutical Market Research Association (EPHMRA), carrying the aim to ...